Kenaf seed supercritical fluid extract reduces aberrant crypt foci formation in azoxymethane-induced rats

Experimental and Toxicologic Pathology

Volumn 64, Issue 3, 2012, Pages 247-251

  Ghafar, Siti Aisyah Abd ^a   Yazan, Latifah Saiful ^a   Tahir, Paridah Md ^a   Ismail, Maznah ^a  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

Author keywords

Aberrant crypt foci; Hibiscus cannabinus (kenaf); Kenaf seed; Sprague Dawley; Supercritical fluid extraction

Indexed keywords

ANTINEOPLASTIC AGENT; HIBISCUS CANNABINUS EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ABERRANT CRYPT FOCUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; CANCER RISK; COLON CANCER; COLON CARCINOMA; CONTROLLED STUDY; DRUG EFFECT; HISTOLOGY; IN VIVO STUDY; KENAF; KIDNEY MASS; LIVER WEIGHT; MALE; NONHUMAN; PLANT SEED; RAT; RISK REDUCTION; SUPERCRITICAL FLUID EXTRACTION; WEIGHT GAIN;

ABERRANT CRYPT FOCI; ANIMALS; AZOXYMETHANE; CARCINOGENS; COLONIC NEOPLASMS; HIBISCUS; MALE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEEDS;

HIBISCUS CANNABINUS; MALVACEAE; RATTUS;

EID: 84857030121     PISSN: 09402993     EISSN: 16181433     Source Type: Journal    
DOI: 10.1016/j.etp.2010.08.016     Document Type: Article

References (47)

1. Agbor G.A., Oben J.E., Ngogang J.Y. Haematinic activity of Hibiscus cannabinus. Afr J Biotechnol 2005, 4:833-837.
2. American Cancer Society: colorectal cancer facts and figure 2008-2010 2008, American Cancer Society, Atlanta, GA, USA, www.acs.gov (accessed February 14, 2010).
3. Awad A.B., Fink C.S. Phytosterols as anticancer dietary components: evidence and mechanism of action. J Nutr 2000, 22:2127-2130. [review].
4. Awad A.B., Henandez A.Y.T., Fink C.S., Mendel S.L. Effect of dietary phytosterols on cell proliferation and protein kinase C activity in rat colonic mucosa. Nutr Cancer 1997, 27:210-215.
5. Berger A., Jones P.J.H., Abumweis S.S. Plant sterols: factors affecting their efficacy and safety as functional food ingredients. Lipids Health Dis 2004, 3:5-23.
6. Bird R.P. Observation and quantification of aberrant crypts in the murine colon treated with a colon carcinogen: preliminary findings. Cancer Lett 1987, 37:147-151.
7. Bird R.P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett 1995, 93(1):55-71. [review].
8. Boateng J.A., Varghese M., Walker L.T., Shackelford L.A., Chawan C.B. Inhibitory effects of selected dry beans (Phaselous spp. L.) on azoxymethane-induced formation of aberrant crypt foci in Fisher 344 male rats. Nutr Res 2007, 27:640-646.
9. Bunpo P., Kataoka K., Arimochi H., Nakayama H., Kuwahara T., Bando Y. Inhibitory effects of centella asiatica on azoxymethane-induced aberrant crypt focus formation and carcinogenesis in the intestines of F344 rats. Food Chem Toxicol 2004, 42(12):1987-1997.
10. Chan K.M., Maznah I. Supercritical carbon dioxide fluid extraction of Hibiscus cannabinus L. seed oil: a potential solvent-free and high antioxidative edible oil. Food Chem 2009, 114:970-975.
11. Cheng L., Lai M.D. Aberrant crypt foci as microscopic precursors of colorectal cancer. World J Gastroenterol 2003, 9:2642-2649.
12. Choi Y.H., Kong K.R., Kim Y.A., Jung K.O., Kil J.H., Rhee S.H., et al. Induction of Bax and activation of caspases during β-sitosterol-mediated apoptosis in human colon cancer cells. Int J Oncol 2003, 23:1657-1662.
13. Cook M.G., McNamara P. Effect of dietary vitamin E on dimethylhydrazine-induced colonic tumors in mice. Cancer Res 1980, 40(4):1329-1331.
14. Dempsey J.M. Fiber crops 1975, The University Presses of Florida, Gainesville.
15. Dreshner E.E., Cohen B.J., Raicht R.F. The kinetics of the protective effect of β-sitosterol against MNU-induced colonic neoplasia. J Cancer Res Clin Oncol 1982, 103:49-54.
16. Dwivedi C., Muller L.A., Goetz-Parten D.E., Kaperson K., Mistry V.V. Chemopreventive effects of dietary mustard oil on colon tumor development. Cancer Lett 2003, 196(1):29-34.
17. Fraser P.D., Bramley P.M. The biosynthesis and nutritional uses of carotenoids. Prog Lipid Res 2004, 43:228-265. [review].
18. Guthrie N., Gapor A., Chambers A.F., Carroll K.K. Inhibition of proliferation of estrogen receptor-negative MDA-MB-435 and tamoxifen alone and in combination. J Nutr 1997, 127:544-548.
19. Janezic S.A., Rao A.V. Dose-dependent effect of dietary phytosterols on epithelial cell proliferation of the murine colon. Food Chem 1992, 30:611-616.
20. Kobaisy M., Tellez M.R., Webber C.L., Dayan F.E., Schrader K.K., Wedge D.E. Phytotoxic and fungitoxic activities of the essential oil of kenaf (Hibiscus cannabinus L.) leaves and its composition. J Agric Food Chem 2001, 49:3768-3771.
21. Kritchevsky D., Chen S.C. Phytosterols-health benefits and potential concerns: a review. Nutr Res 2005, 25:413-428. [review].
22. Lipkin M., Uehara K., Winawar S., Sanchez A., Bauer C., Philips R., et al. Seventh-day adventist vegetarians have a quiescent proliferative activity in colonic mucosa. Cancer Lett 1985, 26:139-144.
23. Mardi Proceedings of the third technical review meeting on the National Kenaf Research Project, May 25th-26th 2004.
24. Masako O., Masatoshi W., Masako N., Ayako T., Takashi S., Hitoshi N. Differential staining of dysplastic aberrant crypt foci in the colon facilitates prediction of carcinogenic potentials of chemicals in rats. Cancer Lett 2005, 220:67-74.
25. Mohamed A., Bahrdwaj H., Hamama A., Webber C. Chemical composition of kenaf (Hibiscus cannabinus L.) seed oil. Ind Crops Prod 1995, 4:157-165.
26. National Cancer Registry. National Cancer Report 2005. (accessed February 23, 2010). http://www.crc.gov.my/ncr.
27. Nesaretnam K., Guthrie N., Chamber A.F., Carroll K.K. Effect of tocotrienols on the growth of human breast cancer cell line in culture. Lipids 1995, 30:1139-1143.
28. Nesaretnam K., Radhakrishnan A., Slvaduray K.R., Reiman K., Pailoor J., Razak G., et al. Effect of palm oil carotene on breast tumorigenicity in nude mice. Lipids 2002, 37:557-560.
29. Nesaretnam K., Stephen R., Dils R., Darbre P. Tocotrienols inhibit the growth of human breast cancer cells irrespective of estrogen receptor status. Lipids 1998, 33:461-469.
30. Nkondjock A., Shatenstein B., Maisonneuve P., Ghadirian P. Specific fatty acids and human colorectal cancer. Cancer Detect Prevent 2003, 27(1):55-56.
31. No H.N., Kwon H., Park Y.G., Cheon C., Park J.S., Park T., et al. Dietary quarcetin inhibits 1,2-dimethylhydrazine-induced liver DNA damage or precancerous lesion formation in rats. Nutr Res 2007, 27:659-664.
32. Nyam K.L., Tan C.P., Lai O.M., Long K., Che Man Y.B. Physicochemical properties and bioactive compounds of selected seed oils. LWT-Food Sci Technol 2009, 42:1396-1403.
33. Ozkal S.G., Salgin U., Yener M.E. Supercritical carbon dioxide extraction of hazelnut oil. J Food Eng 2005, 69(2):217-223.
34. Pretlow T.P., Cheyer C., O'Riordan M.A. Aberrant crypt foci and colon tumors in F344 rats have similar increases in proliferative activity. Int J Cancer 1994, 56:599-602.
35. Pretlow T.P., O'Riordan M.A., Pretlow T.G., Stellato T.A. Aberrant crypts in human colonic mucosa: putative preneoplastic lesions. J Cell Biochem 1992, 16G(Suppl.):55-62.
36. Pretlow T.P., O'Riordan M.A., Somich G.A., Aini S.B., Pretlow T.G. Aberrant crypts correlate with tumor incidence in F344 rats treated with azoxymethane and phytate. Carcinogenesis 1992, 13:1509-1512.
37. Pretlow T.P., Roukhadze E.V., O'Riordan M.A., Chan J.C., Amini S.B., Stellato T.A. Carcinoembryonic antigen in human colonic aberrant crypt foci. Gastroenterology 1994, 107:1719-1725.
38. Raicht R.F., Cohen L.I., Fazzini E.P., Sarwal A.N., Takahashi M. Protective effect of plant sterols against chemically induced colon tumors in rats. Cancer Res 1980, 40:403-405.
39. Roncucci L., Stamp D., Medline A., Cullen J.B., Bruce W.R. Identification and quantification of aberrant crypt foci and microadenomas in the human colon. Hum Pathol 1991, 22:287-295.
40. Ruiz M.L., Castillo D., Dobson D., Brennan R., Gordon S. Genotypic variation in fatty acid content of blackcurrant seeds. J Agric Food Chem 2002, 50:332-335.
41. Sambanthamurthi R., Sundram K., Tan Y. Chemistry and biochemistry of palm oil. Prog Lipid Res 2000, 39:507-508.
42. Shivapurkar N., Tang Z., Frost A., Alabaster O. Inhibition of progression of aberrant crypt foci and colon tumor development by vitamin E and β-carotene in rats on a high risk diet. Cancer Lett 1995, 91:125-132.
43. Sim I.M., Pretlow T.G., Amini S.B., Pretlow T.P. Identification of dysplasia in human colonic aberrant crypt foci. Am J Pathol 1997, 150:1805-1813.
44. Sumiyoshi H. Effects of vitamin E deficiency on 1,2-dimethylhydrazine-induced intestinal carcinogenesis in rats. Hiroshima J Med Sci 1985, 34:363-369.
45. Vinay K., Ramzi S.C., Stanley L.R. Basic pathology 2003, Elsevier, p. 178-80 [Books]. 7th edition.
46. Wang L., Weller C.L. Recent advances in extraction of nutraceutical from plants. Food Sci Technol 2006, 17:300-312. [review].
47. Williams D., Verghese M., Walker L.T., Boateng J., Shackelford L., Chawan C.B. Flax seed oil and flax seed meal reduce the formation of aberrant crypt foci (ACF) in azoxymethane-induced colon cancer in Fisher 344 male rats. Food Chem Toxicol 2007, 45:153-159.